Correlation Engine 2.0
Clear Search sequence regions

Sizes of these terms reflect their relevance to your search.

The urgency of the search for inexpensive and effective drugs with localized action for the treatment of rheumatoid arthritis continues unabated. In this study, for the first time we investigated the Cytos-11 antisense oligonucleotide suppression of TNF-α gene expression in a rat model of rheumatoid arthritis induced by complete Freund's adjuvant. Cytos-11 has been shown to effectively reduce peripheral blood concentrations of TNF-α, reduce joint inflammation, and reduce pannus development. The results achieved following treatment with the antisense oligonucleotide Cytos-11 were similar to those of adalimumab (Humira®); they also compared favorably with those results, which provides evidence of the promise of drugs based on antisense technologies in the treatment of this disease.


Tatyana P Makalish, Ilya O Golovkin, Volodymyr V Oberemok, Kateryna V Laikova, Zenure Z Temirova, Olesya A Serdyukova, Ilya A Novikov, Roman A Rosovskyi, Andrey I Gordienko, Evgeniya Yu Zyablitskaya, Elvina A Gafarova, Kseniya A Yurchenko, Iryna I Fomochkina, Anatoly V Kubyshkin. Anti-Rheumatic Effect of Antisense Oligonucleotide Cytos-11 Targeting TNF-α Expression. International journal of molecular sciences. 2021 Jan 20;22(3)

Expand section icon Mesh Tags

Expand section icon Substances

PMID: 33498456

View Full Text